These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2623976)

  • 1. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency.
    Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N
    Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of different doses of Irtemazole in repeated application.
    Kamilli I; Gresser U; Zöllner N
    Z Rheumatol; 1991; 50(1):23-8. PubMed ID: 1905451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N; Griebsch A; Fink JK
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract]   [Full Text] [Related]  

  • 5. Uricosuric effect of irtemazole in healthy subjects.
    Gresser U; Zöllner N
    Klin Wochenschr; 1989 Oct; 67(19):971-5. PubMed ID: 2615290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
    Fujimori S; Ooyama K; Ooyama H; Moromizato H
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1035-8. PubMed ID: 22132953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uricosuric effect of different doses of irtemazole in normouricaemic subjects.
    Gresser U; Kamilli I; Kronawitter U; Zöllner N
    Eur J Clin Pharmacol; 1990; 38(5):489-91. PubMed ID: 2379534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of benzbromaron in gout patients with limited kidney function].
    Kuzmits R; Bresnik W; Müller MM
    Fortschr Med; 1979 Nov; 97(44):2057-61. PubMed ID: 511087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS; Fox IH
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benziodarone therapy in hyperuricemia in the aged].
    Ravera M; Ugo C
    G Gerontol; 1970 Sep; 18(9):876-9. PubMed ID: 5517231
    [No Abstract]   [Full Text] [Related]  

  • 13. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
    Yu TF
    J Rheumatol; 1976 Sep; 3(3):305-12. PubMed ID: 978666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid onset of uricosuria after oral administration of irtemazole, an uricosuric substance.
    Gresser U; Kronawitter U; Adjan O; Zöllner N
    Klin Wochenschr; 1989 Oct; 67(20):1058-60. PubMed ID: 2586012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperuricemic lignans from the leaves of Phyllanthus niruri.
    Murugaiyah V; Chan KL
    Planta Med; 2006 Nov; 72(14):1262-7. PubMed ID: 16953466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of allopurinol and benziodarone in prolonged treatment of hyperuricemia due to chronic renal insufficiency].
    Bianchi Porro G; Petrillo M; Bianchessi M
    Minerva Med; 1972 Mar; 63(17):1000-9. PubMed ID: 5016057
    [No Abstract]   [Full Text] [Related]  

  • 19. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation and uric acid lowering effect of benzbromarone in patients with liver cirrhosis - evidence for active benzbromarone metabolites?
    Walter-Sack I; de Vries JX; von Bubnoff A; Pfleilschifter V; Raedsch R
    Eur J Med Res; 1995 Oct; 1(1):16-20. PubMed ID: 9392688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.